1461084973-0752df22-edd7-4a66-974f-1230d7153aa1

1. A system, comprising:
a memory to store instructions; and
a processor, communicatively coupled to the memory, that facilitates execution of the instructions to perform operations, comprising:
monitoring air quality of a residential house to establish a data point with respect to an air pollutant extant within the residential house; and
broadcasting the data point to a server that establishes a unique environmental fingerprint for the residential house using the data point as a function of the air pollutant extant within the residential house.
2. The system of claim 1, wherein the unique environmental fingerprint for the residential house is dependent on a characteristic of the residential house.
3. The system of claim 1, wherein the air pollutant comprises a group of air pollutants comprising one of an air borne particulate matter, a volatile organic compound, a nitrogen oxide, a carbon monoxide, a carbon dioxide, a combustible gas, or a formaldehyde.
4. The system of claim 1, wherein the monitoring further comprises one of identifying a temperature or a relative humidity.
5. The system of claim 1, wherein the monitoring further comprises supplying power to a group of sensors comprising one of a particulate sensor, a temperature sensor, a relative humidity sensor, a volatile organic compound sensor, a nitrogen oxides sensor, a carbon monoxide sensor, a combustible gas sensor, a carbon dioxide sensor, or a formaldehyde sensor.
6. The system of claim 5, wherein the supplying of power is utilized to pre-heat a group of sensors comprising one of the volatile organic compound sensor, the nitrogen oxides sensor, the combustible gas sensor, the carbon dioxide sensor, or the formaldehyde sensor.
7. The system of claim 5, wherein the particulate sensor comprises an audiovisual indicator configured to raise an alarm to alert a user regarding an elevated level of the air pollutant extant within the residential house.
8. A system, comprising:
an air quality monitor located in a residential house, the air quality monitor configured to measure a level of an air pollutant, the air quality monitor is communicatively coupled to a server, wherein the server is configured to generate a unique environmental fingerprint as a function of the air pollutant extant within the residential house.
9. The system of claim 8, wherein the server is further configured to monitor the level of the air pollutant as a function of data broadcast by the air quality monitor.
10. The system of claim 9, wherein the server compares the level of the air pollutant against a threshold deviation value that is a function of the unique environmental fingerprint and in response to the level of the air pollutant exceeding the threshold deviation, the server broadcasts a notification to the air quality monitor to activate an audiovisual warning indicator.
11. The system of claim 9, wherein the server compares the level of the air pollutant against a threshold deviation value that is a function of the unique environmental fingerprint and in response to the level of the air pollutant exceeding the threshold deviation, the server broadcasts a notification to a user to take remedial action to take action to evacuate the air pollutant.
12. The system of claim 8, wherein the server is further configured to compare the level of the air pollutant against a unique environmental fingerprint determined by the server, wherein the unique environmental fingerprint is associated with the residential house.
13. The system of claim 12, wherein in response to an upward deviation between the level of the air pollutant and the unique environmental fingerprint, the server broadcasts a notification to a user to take remedial action to abate the upward deviation of the air pollutant.
14. The system of claim 13, wherein the server broadcasts the notification to the user through use of a group of notification services comprising one of a short message service (SMS),a multimedia messaging service (MMS), a paging service, an e-mail, or telephonically.
15. The system of claim 12, wherein in response to an upward deviation between the level of the air pollutant and the unique environmental fingerprint associated with the residential house, the server broadcasts a notification to the air quality monitor to activate an audiovisual warning indicator.
16. The system of claim 8, wherein the air quality monitor includes a radio module and a sensor component.
17. The system of claim 16, wherein the radio module is configured to wirelessly communicate with a wireless access point located in the residential house or the server that is located remotely.
18. The system of claim 16, wherein the radio module is configured to wirelessly communicate with a second air quality monitor located in a second location within the residential house.
19. A method, comprising:
receiving, by a system comprising a processor, data associated with a level of an air pollutant within a multi-family dwelling;
establishing, by the system, a baseline environmental fingerprint for the multi-family dwelling as a function of the level of the air pollutant extant within the multi-family dwelling;
monitoring, by the system, subsequent data associated with the level of the air pollutant within the multi-family dwelling for a deviation from the baseline environmental fingerprint; and
in response to the deviation from the baseline environmental fingerprint, transmitting, by the system, a notification to an air quality monitor situated within the multi-family dwelling to activate an audiovisual warning indicator.
20. The method of claim 19, wherein a plug computer compiles, stores, or processes the data associated with the level of the air pollutant within the multi-family dwelling.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A dosage unit formulation for the intrathecal treatment of pain, comprising a therapeutically effective amount of a triptan to treat non-migrainous tissue pain when administered intrathecally, in combination with a pharmaceutically acceptable carrier for intrathecal administration.
2. The formulation of claim 1, wherein the triptan is selected from the group consisting of rizatriptan, eletriptan, naratriptan, zolmitriptan, frovatriptan, sumatriptan, almotriptan, and combinations thereof.
3. The formulation of claim 1 further comprising a second agent for pain control.
4. The formulation of claim 3 wherein the second agent is selected from the group consisting of morphine, clonidine, fentanyl and baclofen.
5. A method of treating pain, comprising administering intrathecally to a patient in need thereof an effective amount of a triptan to treat non-migrainous tissue pain when administered intrathecally, in combination with a pharmaceutically acceptable carrier for intrathecal administration.
6. The method of claim 5 wherein the triptan is selected from the group consisting of rizatriptan, eletriptan, naratriptan, zolmitriptan, frovatriptan, sumatriptan, almotriptan, and combinations thereof.
7. The method of claim 5 comprising administering the triptan in combination with a second agent for pain control.
8. The method of claim 7 wherein the second agent is selected from the group consisting of an opiate, clonidine, fentanyl and baclofen.
9. The method of claim 5 comprising administering the triptan in combination with gabapentin or pregabalin.
10. The method of claim 5 wherein the triptan is administered to a patient for the treatment of a condition selected from the group consisting of cancer pain, chronic back pain, rheumatoid arthritis, osteoarthitis, post-herpetic neuralgia, and complex regional pain syndrome types I or II, posttraumatic or post-operative pain, diabetic vasculopathy, inflammatory radiculopathy, and inflammatory plexopathies such as brachial plexopathy (Parsonage Turner syndrome) or lumbar plexopathy.
11. The method of claim 5 wherein the patient has neuropathic pain in humans.
12. The method of claim 11 wherein the triptan is administered to a patient for the treatment of a condition selected from the group consisting of HIV neuropathy, chemotherapy-induced neuropathy (such as vincristine toxicity), erythromelalgia, diabetic neuropathy, and inherited painful disorders such as metachromatic leukodystrophy, Friedreich’s ataxia, and Fabry’s disease.
13. The method of claim 5 wherein the triptan is administered for acute pain management.
14. The method of claim 5 for treatment of pain secondary to spinal cord injury.
15. The method of claim 5 wherein the triptan is administered for labor management or spinal blockade for surgery.